Terminated PHASE3 INTERVENTIONAL 1-arm NCT01016522

Safety and Tolerability of the Ketogenic Diet in Amyotrophic Lateral Sclerosis (ALS)

Safety and Tolerability of the Ketogenic Diet in ALS

Sponsor: Cornell University

Conditions Amyotrophic Lateral Sclerosis

Interventions KetoCal

Updated 5 times since 2017 Last updated: Mar 30, 2015 Started: Nov 30, 2009 Primary completion: Feb 28, 2011 Completion: Jan 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Cornell University

See all terminations from Cornell University

Other Amyotrophic Lateral Sclerosis trials with similar outcome

Browse all Amyotrophic Lateral Sclerosis trials

Listed as NCT01016522, this PHASE3 trial focuses on Amyotrophic Lateral Sclerosis and remains terminated or withdrawn. Sponsored by Cornell University, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Nov 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cornell University
Johns Hopkins University
Nutricia North America

Data source: Johns Hopkins University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States